North Macedonia vs Trinidad and Tobago: HPV vaccination coverage in 15-year-olds
North Macedonia
32.0%
in 2024
Trinidad and Tobago
43.0%
in 2024
North Macedonia rank
70th
Trinidad and Tobago rank
67th
HPV vaccination coverage in 15-year-olds over time
- North Macedonia
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 43.0% against 32.0% in North Macedonia, a difference of 11.0%.
That makes Trinidad and Tobago's figure about 1.3 times North Macedonia's.
The two have swapped places 3 times across 6 shared years of data; in 2019 it was North Macedonia ahead.
North Macedonia ranks 70th and Trinidad and Tobago ranks 67th of 74 countries.
North Macedonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | North Macedonia | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 47.0% | 13.0% | 34.0% | North Macedonia |
| 2020s | 45.2% | 32.2% | 13.0% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hpv vaccination coverage in 15-year-olds, North Macedonia or Trinidad and Tobago?
- Trinidad and Tobago, at 43.0% against 32.0% in North Macedonia as of 2024.
- What is the difference in hpv vaccination coverage in 15-year-olds between North Macedonia and Trinidad and Tobago?
- 11.0%, with Trinidad and Tobago ahead.
- How many years of comparable data are there for North Macedonia and Trinidad and Tobago?
- 6 years are reported by both, from 2019 to 2024.
- How do North Macedonia and Trinidad and Tobago rank globally for hpv vaccination coverage in 15-year-olds?
- North Macedonia ranks 70th and Trinidad and Tobago ranks 67th of 74 countries.
- Where does this data come from?
- WHO & UNICEF (2025) – processed by Our World in Data, published as HPV vaccination coverage in 15-year-olds. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of 15-year-olds who received doses of the human papillomavirus vaccine between the ages of 9 and 14.